KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $671.9 million.

  • Oscar Health's Cash from Operations rose 9373.25% to $671.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 1192.62%. This contributed to the annual value of $1.1 billion for FY2025, which is 1192.62% up from last year.
  • Per Oscar Health's latest filing, its Cash from Operations stood at $671.9 million for Q4 2025, which was up 9373.25% from -$964.7 million recorded in Q3 2025.
  • Over the past 5 years, Oscar Health's Cash from Operations peaked at $878.5 million during Q1 2025, and registered a low of -$1.1 billion during Q3 2023.
  • Moreover, its 5-year median value for Cash from Operations was $255.7 million (2022), whereas its average is $100.0 million.
  • As far as peak fluctuations go, Oscar Health's Cash from Operations tumbled by 16915.95% in 2021, and later surged by 33909.05% in 2022.
  • Over the past 5 years, Oscar Health's Cash from Operations (Quarter) stood at $34.5 million in 2021, then soared by 339.09% to $151.4 million in 2022, then surged by 96.09% to $296.9 million in 2023, then grew by 16.83% to $346.8 million in 2024, then surged by 93.73% to $671.9 million in 2025.
  • Its Cash from Operations was $671.9 million in Q4 2025, compared to -$964.7 million in Q3 2025 and $509.1 million in Q2 2025.